Loading...

Maria Mudryj, PhD

Title(s)Professor, Medical Microbiology And Immunology
SchoolUniversity of California, Davis
Phone530-754-6090
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Baek HB, Lombard AP, Libertini SJ, Fernandez-Rubio A, Vinall R, Gandour-Edwards R, Nakagawa R, Vidallo K, Nishida K, Siddiqui S, Wettersten H, Landesman Y, Weiss RH, Ghosh PM, Mudryj M. XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 2018 Oct 02; 9(77):34567-34581. PMID: 30349650.
      View in: PubMed
    2. D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 2017 11 16; 36(46):6359-6373. PMID: 28745319.
      View in: PubMed
    3. Lombard AP, Mudryj M. The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer. 2015 Oct; 22(5):R265-77. PMID: 26229034.
      View in: PubMed
    4. Lombard AP, Lim RM, Nakagawa RM, Vidallo KD, Libertini SJ, Platero AJ, Mudryj M. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncol Rep. 2015 Sep; 34(3):1526-32. PMID: 26166215.
      View in: PubMed
    5. Lombard AP, Mooso BA, Libertini SJ, Lim RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM, Mudryj M. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Mol Carcinog. 2016 May; 55(5):757-67. PMID: 25865490.
      View in: PubMed
    6. Savoy RM, Chen L, Siddiqui S, Melgoza FU, Durbin-Johnson B, Drake C, Jathal MK, Bose S, Steele TM, Mooso BA, D'Abronzo LS, Fry WH, Carraway KL, Mudryj M, Ghosh PM. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocr Relat Cancer. 2015 Jun; 22(3):369-86. PMID: 25759396.
      View in: PubMed
    7. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. PMID: 25158272.
      View in: PubMed
    8. Mudryj M, Tepper CG. On the origins of the androgen receptor low molecular weight species. Horm Cancer. 2013 Oct; 4(5):259-69. PMID: 23860689.
      View in: PubMed
    9. Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 2012 Dec; 19(6):759-77. PMID: 22993077.
      View in: PubMed
    10. Libertini SJ, Chen H, al-Bataina B, Koilvaram T, George M, Gao AC, Mudryj M. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells. Prostate. 2012 May 01; 72(6):649-60. PMID: 21837779.
      View in: PubMed
    11. Jathal MK, Chen L, Mudryj M, Ghosh PM. Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block. Immunol Endocr Metab Agents Med Chem. 2011 Jun; 11(2):131-149. PMID: 21603064.
      View in: PubMed
    12. Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung HJ, Ghosh PM, Mudryj M. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr Relat Cancer. 2010 Dec; 17(4):857-73. PMID: 20634343.
      View in: PubMed
    13. Chen H, Libertini SJ, Wang Y, Kung HJ, Ghosh P, Mudryj M. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J Biol Chem. 2010 Jan 22; 285(4):2368-74. PMID: 19946123.
      View in: PubMed
    14. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. PMID: 19188148.
      View in: PubMed
    15. Devlin HL, Mudryj M. Progression of prostate cancer: multiple pathways to androgen independence. Cancer Lett. 2009 Feb 18; 274(2):177-86. PMID: 18657355.
      View in: PubMed
    16. Devlin HL, Mack PC, Burich RA, Gumerlock PH, Kung HJ, Mudryj M, deVere White RW. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells. Mol Cancer Res. 2008 May; 6(5):808-18. PMID: 18505925.
      View in: PubMed
    17. Libertini SJ, Tepper CG, Rodriguez V, Asmuth DM, Kung HJ, Mudryj M. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res. 2007 Oct 01; 67(19):9001-5. PMID: 17909000.
      View in: PubMed
    18. Mudryj M, Reay E, Beckett L, Dandekar S, deVere White R, Gandour-Edwards R. Novel p53/p130 axis in bladder tumors. Urology. 2007 Sep; 70(3):608-12. PMID: 17905135.
      View in: PubMed
    19. Libertini SJ, Tepper CG, Guadalupe M, Lu Y, Asmuth DM, Mudryj M. E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis. Prostate. 2006 Jan 01; 66(1):70-81. PMID: 16114066.
      View in: PubMed
    20. Libertini SJ, Robinson BS, Dhillon NK, Glick D, George M, Dandekar S, Gregg JP, Sawai E, Mudryj M. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res. 2005 Dec 01; 65(23):10700-8. PMID: 16322214.
      View in: PubMed
    21. Nguyen H, Mudryj M, Guadalupe M, Dandekar S. Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology. 2003 Jul 20; 312(1):245-53. PMID: 12890637.
      View in: PubMed
    22. Dhillon NK, Mudryj M. Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes Immun. 2003 Jul; 4(5):336-42. PMID: 12847548.
      View in: PubMed
    23. Dhillon NK, Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene. 2002 Jul 11; 21(30):4626-34. PMID: 12096339.
      View in: PubMed
    24. Ndolo T, Dhillon NK, Nguyen H, Guadalupe M, Mudryj M, Dandekar S. Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle. J Virol. 2002 Apr; 76(8):3587-95. PMID: 11907198.
      View in: PubMed
    25. Fojas de Borja P, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001 Oct 15; 20(20):5737-47. PMID: 11598016.
      View in: PubMed
    26. Tepper CG, Seldin MF, Mudryj M. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. Exp Cell Res. 2000 Oct 10; 260(1):9-19. PMID: 11010806.
      View in: PubMed
    27. Afshari CA, Rhodes N, Paules RS, Mudryj M. Deregulation of specific E2F complexes by the v-mos oncogene. Oncogene. 1997 Jun 26; 14(25):3029-38. PMID: 9223666.
      View in: PubMed
    28. Afshari CA, Nichols MA, Xiong Y, Mudryj M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ. 1996 Aug; 7(8):979-88. PMID: 8853893.
      View in: PubMed
    29. Wade M, Kowalik TF, Mudryj M, Huang ES, Azizkhan JC. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol. 1992 Oct; 12(10):4364-74. PMID: 1328853.
      View in: PubMed
    30. Devoto SH, Mudryj M, Pines J, Hunter T, Nevins JR. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell. 1992 Jan 10; 68(1):167-76. PMID: 1310073.
      View in: PubMed
    31. Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 1991 Jun 28; 65(7):1243-53. PMID: 1829647.
      View in: PubMed
    32. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell. 1991 Jun 14; 65(6):1053-61. PMID: 1828392.
      View in: PubMed
    33. Nevins JR, Chellappan SP, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T, Pines J. E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harb Symp Quant Biol. 1991; 56:157-62. PMID: 1840249.
      View in: PubMed
    34. Mudryj M, Hiebert SW, Nevins JR. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 1990 Jul; 9(7):2179-84. PMID: 2141565.
      View in: PubMed
    35. Mudryj M, de Crombrugghe B. Deletion analysis of the mouse alpha 1(III) collagen promoter. Nucleic Acids Res. 1988 Aug 11; 16(15):7513-26. PMID: 3412893.
      View in: PubMed
    36. Setoyama C, Frunzio R, Liau G, Mudryj M, de Crombrugghe B. Transcriptional activation encoded by the v-fos gene. Proc Natl Acad Sci U S A. 1986 May; 83(10):3213-7. PMID: 3010284.
      View in: PubMed
    37. Liau G, Mudryj M, de Crombrugghe B. Identification of the promoter and first exon of the mouse alpha 1 (III) collagen gene. J Biol Chem. 1985 Mar 25; 260(6):3773-7. PMID: 3972847.
      View in: PubMed
    38. de Crombrugghe B, Liau G, Setoyama C, Schmidt A, McKeon C, Mudryj M. Structural and functional studies on the interstitial collagen genes. Ciba Found Symp. 1985; 114:20-33. PMID: 2998711.
      View in: PubMed
    39. de Crombrugghe B, Schmidt A, Liau G, Setoyama C, Mudryj M, Yamada Y, McKeon C. Structural and functional analysis of the genes for alpha 2(I) and alpha 1(III) collagens. Ann N Y Acad Sci. 1985; 460:154-62. PMID: 3868943.
      View in: PubMed
    40. Yamada Y, Liau G, Mudryj M, Obici S, de Crombrugghe B. Conservation of the sizes for one but not another class of exons in two chick collagen genes. Nature. 1984 Jul 26-Aug 1; 310(5975):333-7. PMID: 6547770.
      View in: PubMed
    41. Yamada Y, Mudryj M, de Crombrugghe B. A uniquely conserved regulatory signal is found around the translation initiation site in three different collagen genes. J Biol Chem. 1983 Dec 25; 258(24):14914-9. PMID: 6689169.
      View in: PubMed
    42. Yamada Y, Mudryj M, Sullivan M, de Crombrugghe B. Isolation and characterization of a genomic clone encoding chick alpha 1 type III collagen. J Biol Chem. 1983 Mar 10; 258(5):2758-61. PMID: 6298201.
      View in: PubMed
    43. Vogeli G, Ohkubo H, Avvedimento VE, Sullivan M, Yamada Y, Mudryj M, Pastan I, de Crombrugghe B. A repetitive structure in the chick alpha 2-collagen gene. Cold Spring Harb Symp Quant Biol. 1981; 45 Pt 2:777-83. PMID: 6942950.
      View in: PubMed
    44. Ohkubo H, Vogeli G, Mudryj M, Avvedimento VE, Sullivan M, Pastan I, de Crombrugghe B. Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7059-63. PMID: 6452631.
      View in: PubMed
    45. Yamada Y, Avvedimento VE, Mudryj M, Ohkubo H, Vogeli G, Irani M, Pastan I, de Crombrugghe B. The collagen gene: evidence for its evolutinary assembly by amplification of a DNA segment containing an exon of 54 bp. Cell. 1980 Dec; 22(3):887-92. PMID: 7460017.
      View in: PubMed
    46. de Crombrugghe B, Mudryj M, DiLauro R, Gottesman M. Specificity of the bacteriophage lambda N gene product (pN): nut sequences are necessary and sufficient for antitermination by pN. Cell. 1979 Dec; 18(4):1145-51. PMID: 160286.
      View in: PubMed
    47. Thomas HF, Hartman PE, Mudryj M, Brown DL. Nitrous acid mutagenesis of duplex DNA as a three-component system. Mutat Res. 1979 Jul; 61(2):129-51. PMID: 314585.
      View in: PubMed